市場調査レポート

ドラッグデリバリーにおけるナノテクノロジーの世界市場

Nanotechnology in Drug Delivery

発行 Global Industry Analysts, Inc. 商品コード 297187
出版日 ページ情報 英文 202 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
ドラッグデリバリーにおけるナノテクノロジーの世界市場 Nanotechnology in Drug Delivery
出版日: 2014年01月01日 ページ情報: 英文 202 Pages
概要

当レポートでは、世界のドラッグデリバリーにおけるナノテクノロジー市場について調査分析を行い、ナノ結晶、ナノキャリアの各ドラッグデリバリー技術について分析するとともに、米国、カナダ、日本、欧州、アジア太平洋地域、ラテンアメリカ、世界のその他の諸国の各市場について包括的に分析し、2009年〜2018年の見通し、主要企業などについてまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション、調査方法、製品の定義

第2章 エグゼクティブサマリー

  • 見通し
  • 産業の概要
    • ナノテクノロジーのイントロダクション
    • ナノテクノロジーの影響
    • ナノテクノロジーはどのようにドラッグデリバリーに役立つのか
    • ドラッグデリバリー技術
    • 高度ドラッグデリバリーシステムの発展の主な要件
    • ドラッグデリバリー:医療におけるナノテクノロジーの主要応用分野
    • ナノテクノロジーの進化における主な出来事
    • 貧水溶性ドラッグへの利用
    • 新規治療のデリバリーにおける役割
    • 標的デリバリーのニーズ
    • 標的デリバリーの臨床利用の問題
    • ドラッグデリバリー担体としてのNEMデバイス
    • ナノテクノロジー:ドラッグのコデリバリーの追及
    • 多剤耐性を減らす/避けるナノ粒子
    • 多機能治療のデリバリーを可能にするナノスケールデバイス
    • セラノスティクス:ナノテクノロジーによるコデリバリーの潜在的な応用
    • ナノエマルジョンが広がり始めている
    • ナノエマルジョンの用途の広がり
  • 動向と課題
  • ナノテクノロジーによるドラッグデリバリー
  • 製品の概要
    • ナノテクノロジーとナノ医療の定義
    • ドラッグデリバリーにおけるナノ粒子の応用
    • ナノテクノロジーによるドラッグデリバリー技術
    • ナノ結晶
    • ナノキャリア
    • ナノ構造合成
    • トップダウンアプローチ
    • ボトムアップアプローチ
    • 最適なナノ粒子デザインの必要条件
    • ナノ粒子のサイズと表面電荷
    • ペグ化と官能化配位子
  • 最近の産業活動
  • 主要企業
  • 世界市場の概要

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他の欧州諸国
  • アジア太平洋地域
    • 中国
    • その他のアジア太平洋地域の諸国
  • ラテンアメリカ
  • 世界のその他の諸国

第4章 競合状況

目次
Product Code: MCP-7808

This report analyzes the worldwide markets for Nanotechnology in Drug Delivery in US$ Million. The Global Market is further analyzed by the following Drug Delivery Technologies: Nanocrystals, and Nanocarriers. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 60 companies including many key and niche players such as -

Access Pharmaceuticals, Inc.
Alkermes PLC
Aquanova AG
Camurus AB
Capsulution Pharma AG
Celgene, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Nanotechnology and Nanomedicine
    • Nanotechnology in Drug Delivery
    • Nanotechnology Drug Delivery Systems
      • Nanocrystals
      • Nanocarriers

II. EXECUTIVE SUMMARY

1. OUTLOOK

  • Nanotechnology - the Next Big Thing in Drug Development
  • Present Status and Opportunities that Lie Ahead
  • Current & Future Analysis
  • Major Market Drivers
  • Nanocrystals Outperform Nanocarriers
  • Liposomes - Leading the Way
  • Dendrimers Serve as a Base to Build Multifunctional Nanodevices

2. INDUSTRY OVERVIEW

  • Nanotechnology - An Introduction
  • Impact of Nanotechnology in a Nutshell
  • How Does Nanotechnology Help Drug Delivery?
  • Drug Delivery Technologies - A Fast Rising Market
  • Select Key Requirements for Development of Advanced Drug Delivery Systems
  • Drug Delivery - A Key Application of Nanotechnology in Medicine
  • Major Milestones in the Evolution of Nanotechnology- based Drug Delivery Materials
    • Table 1: Global Nanomedicine market by Application: Percentage Breakdown of the Market for Drug Delivery, Implants, In vivo Diagnostics and In vitro Diagnostics (includes corresponding Graph/Chart)
  • Nanotechnology Rescues Poor Water Soluble Drugs from Abandonment
  • Nanotechnology Promises to Play Enabling Role in Delivery of New Therapeutics
  • The Need for Targeted Delivery
  • The Difficulty in Clinical Use of Targeted Delivery
  • NEM Devices as Drug Delivery Vehicles
  • Nanotechnology - In Pursuit of Co-Delivery of Drugs
  • Nanoparticles in Minimizing or Averting Multi-Drug Resistance
  • Nanoscale Devices Enable Delivery of Multi-functional Therapeutics
  • Theranostics - A Potential Application of Nanotechnology-based Co-Delivery
  • Nanoemulsions Begin to Make a Mark
  • Growing Application of Nanoemulsions
    • A Review of Select Investigational Nanoemulsion Formulations

3. TRENDS & ISSUES

  • Tough Market Conditions Drive Interest in Nanotechnology-Based Drug Delivery
    • Table 2: Select Major Drugs Scheduled to Lose Patent Protection through 2013-2016: Annual Global Sales for Years 2010 & 2011
    • Table 3: Number of Drugs (NMEs and NBEs) Approved by US FDA: 2001-2012 (includes corresponding Graph/Chart)
    • Table 4: Number of Drugs (NMEs and NBEs) Approved by European Medicines Agency: 2010-2012 (includes corresponding Graph/Chart)
  • Unmet Needs to Surge Interest in Nanotechnology- based Drug Delivery
  • Narrowing Drug Pipelines and Threat from Generics Raise Interest in Nanotechnology
  • Size - A Critical Factor in Improving Targeting Capability
  • Shape of Drug Carriers More Important than Size - A New Revelation
  • Existing Nanotechnology Drugs are Simple
  • Creation of New Therapeutics - The Next Avenue for Nanotechnology
  • Consumer Pull to Benefit Nanotechnology Based Drugs
  • Oral Therapies to Revel from Advances in Nanotechnology
  • Increasing Funding for Nanotechnology Based Therapeutics Development
    • Table 5: Global Annual Government Funding for Nanotechnology for Years 2003-2012 (includes corresponding Graph/Chart)
  • Convergence of Enabling Technologies - A New Phase in Drug Delivery
  • Cloudy Future Threatens Advanced Drug Delivery Technologies with Premature Demise
  • Increasing Environmental and Health Concerns - A Critical Challenge to Technological Advancement
  • Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement
  • Financial and Economic Challenges Hurt Developmental Efforts
  • Higher Concentration of Research in Academia limits Commercialization
  • Collaborations Assume Importance
  • Nano Drug Delivery to Drive Tremendous Industry Activity Going Ahead
  • Challenges to Leveraging Technological Advancements for Boosting Drug Delivery Efficiency
  • Nanomedicine Regulation - the Approach and the Issues Associated
  • Regulations in Nanotechnology - Still Significant Room Exists for Improvement

4. NANOTECHNOLOGY-BASED DRUG DELIVERY APPLICATIONS

  • Modern Technological Advancements Take Forward Drug Delivery Systems
  • List of Select Nanomedicines Approved by FDA
  • Select Non-targeted Nanoparticles in Drug Delivery in Mid- and Late-Stage Clinical Trials
  • New Technology Enabled Depot Formulations
  • An Insight into Key Areas of Application
  • Cancer Therapy
    • Nanotechnology to Revolutionize Cancer Therapy
    • Nanoparticles Change Therapeutic Index of Chemotherapeutic Agents
      • List of Select Nanoparticle Drug Delivery Systems and Uses in Cancer Therapies
    • A Review of Select Nanotechnology-Based Delivery Systems in Anti-Cancer Therapies
      • Albumin - A Key Delivery Vehicle
      • Micellar Nanoparticle Formulation of Paclitaxel
      • Liposomal Formulation of Anti-Cancer Therapies
      • Dendrimers Finding Extending Use in Nanoparticle based Anti-Cancer Drug Delivery
      • Polymeric Micelles in Cancer Drug Delivery
  • Nanotechnology in Pulmonary Delivery of Drugs
    • Increasing Attention towards Pulmonary Delivery of Nanoparticle-Based Drugs
    • Liposomes - The Popular Choice for Drug Delivery through Lungs
    • Other Nanovehicles in Pulmonary Delivery
    • SLNs in Pulmonary Delivery of Drugs
    • Tuberculosis Treatment - A Major Application of Pulmonary Delivery
    • Nanotechnology in Infectious Disease Treatment
      • Nanotechnology Finds Increasing Role in Fighting Infectious Diseases
    • Liposomes
      • Liposomes - Leading the Way in Antimicrobial Nanotechnology-Based Drug Delivery
      • Overview of Select Liposome-Delivered Antimicrobial Products
    • Polymeric Nanoparticles
    • Solid Lipid Nanoparticles
    • Dendrimers
      • List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
    • Nanotechnology Opening New Avenues in Antiretroviral Therapy
      • Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies
  • Nanotechnology in Delivery of CNS Therapeutics
    • The Blood-Brain Barrier and Effectiveness of Therapeutics
    • Nanoparticles Provide a Safer Means to Circumvent BBB
  • Nanotechnology in Delivery of Therapeutics for Ocular Conditions
    • New Forms of Drug Delivery to Treat Ocular Conditions
    • Efficient Drug Delivery through Micro-sized Implants
  • Pain Management
    • Timed-release Topical Formulation Offers Pain Relief from Arthritis and Acute Injuries
      • MyOmega 3 for Relief from Flares of Gouty Pain
      • MyOmega 3 Comes with Two Pain Relieving Products
      • Nano-Icepearls Particles Technology - The Driver of MyOmega 3
  • Polymeric Nanoparticles Promise Better Treatment for Childhood Leukemia
  • Nano-immunology - Still in Nascent Stages

5. PRODUCT OVERVIEW

  • Defining Nanotechnology and Nanomedicine
  • Applications of Nanoparticles in Drug Delivery
  • Nanotechnology-Based Drug Delivery Technologies by Segment
  • Nanocrystals
  • Nanocarriers
    • Nanostructures in Drug Delivery
      • Features of a Rational Nanocarrier
      • List of Select Nanomaterials Being Studied or Developed for Drug Delivery
      • Drug Delivery Technologies, Forms and Materials
    • Overview of Select Major Nanocarriers
      • Comparison of Key Attributes of Select Major Nanocarriers
      • Liposomes
      • List of Select Drugs/Compounds Demonstrated for Efficacious Liposome-based Delivery
      • Polymeric Nanoparticles
      • List of Select Drugs Demonstrated for Efficacious Polymeric Nanoparticle-based Delivery
      • Dendrimers
      • List of Select Drugs Demonstrated for Efficacious Dendrimer-based Delivery
      • Solid Lipid Nanoparticles (SLNs)
      • Nanotubes
      • List of Select Drugs Demonstrated for Efficacious Nanotube-based Delivery
      • Polymeric Micelles
      • Nanocapsules
      • Fullerenes
  • Nanostructure Synthesis
  • Top-Down Approach
  • Bottom-Up Approach
  • Requisites for Optimal Nanoparticle Design
  • Size and Surface Charge of the Nanoparticle
  • PEGylation and Ligand Functionalization

6. RECENT INDUSTRY ACTIVITY

  • Labtec Changes Name to tesa Labtec
  • Andain Announces Development of Drug Delivery Nano-Particles
  • Bind Therapeutics Teams-up with Pfizer
  • FDA Clears Abraxis's Abraxane for First Line Pancreatic Cancer Treatment
  • pSivida Inks Agreement to Evaluate Tethadur Protein/Antibody Delivery Technology
  • Venus Medicine Research Centre to Invest in Nanotechnology Product Research
  • mPhase Files Patent for New Drug Delivery System Based on Smart Surface Technology
  • Midatech Generates Funding for Development of Chemotherapeutic Gold Nanoparticles
  • Galen Acquires DaunoXome® from Gilead Sciences
  • Exploit Technologies Releases New Delivery System for Worldwide Licensing, Partnering
  • Celator and Cephalon Extend Research Agreement
  • Morphotek Acquires Assets of Tumor-Targeting Peptide Platform from TransMolecular
  • Encap and Lena Join Forces for Developing Nano-Capsule Technology
  • Dolomite Unveils New Microfluidic System for Synthesis of Nanoparticle
  • Osaka Bioventure to Develop Anti-Inflammatory Transdermal Patch in US
  • Quantum Materials and Nanoaxis Form Technology Alliance
  • BioAlliance Gets European Patent for Its Transdrug Nanotechnology
  • Kadmon and Nano Terra Form Joint Venture for Nano-Level Drug Delivery
  • Yissum Announces Successful Pre-Clinical Results for Oral Delivery of Docetaxel Using Nanotechnology
  • Thailand and South Korea Sign MOU for Joint Nanotechnology Research
  • IBM and Institute of Bioengineering and Nanotechnology Utilize Semiconductor Nanotechnology to Treat Infectious Diseases
  • Camurus Enters into License Agreement with Novartis
  • Flamel Technologies Inks Agreement with GlaxoSmithKline
  • Eagle Pharmaceuticals Inks Development and License Agreement with Flamel Technologies
  • Alkermes and Elan Drug Technologies Ink Merger Agreement
  • AAIPharma and CritiTech Enter into Partnership
  • Midatech and Monosol Sign Expanded Collaboration Agreement
  • Celator Receives US Patent for CombiPlex® Technology Platform
  • Sosei Acquires Activus Pharma
  • Charlesson Obtains Funding for Development of Anti-Glaucoma Drug
  • Aphios Obtains US Patent for the Polymer Drug Delivery Nanotechnology Platform
  • Celator to Participate in NCI's Characterization Studies for Nanoparticle Prodrug Delivery System
  • Celgene Takes Over Abraxis BioScience

7. FOCUS ON SELECT PLAYERS

  • Access Pharmaceuticals, Inc. (US)
  • Alkermes PLC (Ireland)
  • Aquanova AG (Germany)
  • Camurus AB (Sweden)
  • Capsulution Pharma AG (Germany)
  • Celgene, Inc. (Canada)
  • Ceramisphere Pty Ltd. (Australia)
  • Crititech LLC (US)
  • EnColl Corporation (US)
  • Enzon Pharmaceuticals, Inc. (US)
  • Flamel Technologies SA (France)
  • Lena Nanoceutics Ltd. (UK)
  • NanoBio® Corporation (US)
  • NanoCarrier Co., Ltd. (Japan)
  • Nano Interface Technology, Inc. (US)
  • pSivida Corp. (US)

8. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)
    • Table 7: World 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2013 & 2018 (includes corresponding Graph/Chart)
    • Table 8: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanocrystals and Nanocarriers Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)
    • Table 9: World 10-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Dollar Sales for Nanocrystals and Nanocarriers Markets for Years 2009, 2013 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Market Overview
    • Select Key Statistics
    • Table 10: Number of Nanotechnology Submissions to CDER by Platform and Application (includes corresponding Graph/Chart)
    • Table 11: Nanotechnology Submissions to CDER by Platform: Percentage Breakdown of Number of Submissions for Liposomes, Nanoparticles, Nanocrystals, Micelles, SPIO and Others (includes corresponding Graph/Chart)
    • Table 12: Nanotechnology Submissions to CDER by Indication/Application: Percentage Breakdown of Number of Submissions for Oncology, Pain Management, Infectious Diseases, MRI, Immunosuppression and Others (includes corresponding Graph/Chart)
    • Table 13: Nanotechnology Submissions to CDER by Route of Administration: Breakdown of Number of Submissions for Intravascular, Inhalation, Oral, Topical and Other Injections (includes corresponding Graph/Chart)
    • Table 14: Liposomal Formulation-Based Submissions to CDER by Route of Administration: Breakdown of Number of Submissions for Intravascular, Inhalation, Oral and Other Injections (includes corresponding Graph/Chart)
    • Table 15: Nanoparticle Formulation-Based Submissions to CDER by Route of Administration: Breakdown of Number of Submissions for Intravascular, Oral, Inhalation, Topical and Other Injections (includes corresponding Graph/Chart)
    • FDA's Regulatory Approach to Nanotechnology Products
      • Regulatory Evolution of Nanomedicine in the US
      • The Perils of Current Regulatory Status on Nanostructures
      • Few Challenges Faced by FDA
    • Competition
      • Overview of Select Key US Nanomedicine Companies Focused on Nano Drug Delivery
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 16: US Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Key Player
  • B. Market Analytics
    • Table 17: Canadian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Nanomedicines in Japan - An Overview
      • List of Select Nanomedicines Approved in Japan
    • Regulations on Nanomedicine in Japan
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 18: Japanese Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • The Rise of Nanotechnology Based Drug Delivery in Europe
    • EU Gears Up for Clarity on Nanomedicine Regulations
    • Harmonization of Regulations - A Key Goal for EMA
  • B. Market Analytics
    • Table 19: European Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)
    • Table 20: European 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2013 & 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Nanotechnology and Nanomedicine in France - An Overview
      • Overview of Select Major French Nanomedicine Companies Focused on Drug Delivery
    • Regulations on Nanomaterials
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 21: French Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Germany - A Regional Hub for Nanomedicine Research
      • Overview of Select Major German Nanomedicine Companies Focused on Nano Drug Delivery
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 22: German Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 23: Italian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • UK Bets on Advancing Nanotechnology
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 24: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 25: Spanish Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 26: Russian Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 27: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • Market Analysis
    • Table 28: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)
    • Table 29: Asia-Pacific 10-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2009, 2013 & 2018 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Current & Future Analysis
    • New Findings Reinforce Role of Silica Nanoparticles in Drug Delivery and Diagnostics
    • Nanotechnology Patent Profile in China
    • Table 30: Number of Patents filed for Nanotechnology-based Drug Delivery in China by Country (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 31: Chinese Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Indian Nanotechnology Market - An Overview
      • Nanotechnology to Spur Indian Pharmaceutical Industry
      • Major Players
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 32: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 33: Latin American Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 34: Rest of World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery Market - Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top